Review Reports
- Zoltán Horváth-Szalai1,2,*,
- Rita Jakabfi-Csepregi1,2 and
- Balázs Szirmay1,2
- et al.
Reviewer 1: Drago Beslo Reviewer 2: Masayuki Nagasawa
Round 1
Reviewer 1 Report
The problem is current. The proposed marker for the inflammatory process is interesting. Maybe it could also be applied to the proposed marker for other possible infections in the future. It is certain that this should be tested on a larger number of samples.
Questions that the authors could further clarify:
1. On the basis of laboratory diagnostics, could any other parameter be taken as a marker for overlooking the disease?
2. Did the literature search lead to similar research and were similar results obtained?
3. You used relevant methods to determine the TAC. Could the DPPH method be used?
Author Response
Please see the attachment.
Author Response File: 
Author Response.pdf
Reviewer 2 Report
Comments for author File: Comments.pdf
Author Response
Please see the attachment.
Author Response File: Author Response.pdf
Round 2
Reviewer 2 Report
I will request minor revision. Please see the attached file in which my review comments are described.
Comments for author File: Comments.pdf
Author Response
Please see the attachment.
Author Response File: Author Response.pdf